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Abstract
Macrophage-specific expression of Arginase-1 is commonly believed to promote inflammation, fibrosis, and wound healing
by enhancing L-proline, polyamine, and Th2 cytokine production. Here, however, we show that macrophage-specific Arg1
functions as an inhibitor of inflammation and fibrosis following infection with the Th2-inducing pathogen Schistosoma
mansoni. Although susceptibility to infection was not affected by the conditional deletion of Arg1 in macrophages,
Arg1
2/flox;LysMcre mice died at an accelerated rate. The mortality was not due to acute Th1/NOS2-mediated hepatotoxicity
or endotoxemia. Instead, granulomatous inflammation, liver fibrosis, and portal hypertension increased in infected
Arg1
2/flox;LysMcre mice. Similar findings were obtained with Arg1
flox/flox;Tie2cre mice, which delete Arg1 in all macrophage
populations. Production of Th2 cytokines increased in the infected Arg1
2/flox;LysMcre mice, and unlike alternatively activated
wild-type macrophages, Arg1
2/flox;LysMcre macrophages failed to inhibit T cell proliferation in vitro, providing an underlying
mechanism for the exacerbated Th2 pathology. The suppressive activity of Arg1-expressing macrophages was independent
of IL-10 and TGF-b1. However, when exogenous L-arginine was provided, T cell proliferation was restored, suggesting that
Arg1-expressing macrophages deplete arginine, which is required to sustain CD4
+ T cell responses. These data identify Arg1
as the essential suppressive mediator of alternatively activated macrophages (AAM) and demonstrate that Arg1-expressing
macrophages function as suppressors rather than inducers of Th2-dependent inflammation and fibrosis.
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Introduction
Arginase 1 (Arg1) is a cytosolic enzyme constitutively expressed
in the liver where it functions in nitrogen elimination by catalyzing
arginine hydrolysis to urea and ornithine [1,2]. Arg1 is also
expressed in macrophages but unlike the constitutive expression
observed in the liver, Arg1 gene expression is tightly regulated by
exogenous stimuli including the Th2 cytokines IL-4 and IL-13
[3,4]. The production of urea removes excess nitrogen from the
body, while ornithine can be used to generate polyamines,
glutamate, and proline, the latter of which is critical to the
synthesis of collagen [5,6]. Arg1 also competes with iNOS
(encoded by Nos2) an enzyme that controls the production of
nitric oxide in IFN-c stimulated classically activated macrophages
(CAMs). Thus, expression of Nos2 and Arg1 currently defines
classically and alternatively activated macrophages (AAMs),
respectively. Nevertheless, while iNOS and Arg1 have been
studied in the context of Th1 responses [7,8], the role of Arg1 in
Th2-polarized immune responses remains unknown.
Mice infected with the parasitic trematode Schistosoma mansoni
are a model of human schistosomiasis and chronic Th2 cytokine-
mediated pathology, as many of the pathological features of the
human diseases are duplicated in the mouse model. S. mansoni
infection leads to the development of a Th2-driven inflammatory
response in response to the eggs deposited in the intestines and
liver by adult worm pairs. The resulting immune response is
driven by the production of Th2 cytokines including IL-4, IL-5,
IL-13, and IL-21, which contribute to the development of hepatic
fibrosis and portal hypertension [2,9,10]. The Th2 response is also
associated with the accumulation of a large number of Arg1-
expressing macrophages in and around the granulomas [10,11].
Because Arg1 regulates the synthesis of the amino acid proline,
which is required for collagen production, numerous studies have
suggested that Arg1 is critically involved in the regulation of
wound healing and fibrosis [2,11,12]. However, the specific
function of Arg1 remains unexplored. A few recent studies have
begun to dissect the function of arginases in immunity by using
RNA interference, macrophage depletion, and the arginase
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these approaches are not specific to the Arg1 isoform nor are they
selective antagonists of Arg1 in macrophages. Because Arg1 mRNA
and Arg1 protein is predominantly produced by macrophages
following infection with S. mansoni [11], we examined whether Arg1
regulates the pathogenesis of Th2 cytokine driven disease by
studying mice with macrophage-specific deletions of Arg1.
Results
Generation and characterization of macrophage-specific
Arg1 null mice
Mice in which a portion of the Arg1 gene was flanked with loxP
sites were crossed with mice expressing the Cre recombinase from
the lysozyme M (LysM) gene (Lyz2
tm1(cre)Ifo), hereafter referred to as
‘LysMcre’ to generate mice in which Arg1 was deleted in
macrophages [16]. It is important to note that although LysM
expression has been observed in several tissues as well as in the
later steps of myeloid lineage differentiation [17,18], inducible
extra-hepatic Arg1 expression is predominantly found in macro-
phages and possibly dendritic cells as recently shown by a IRES-
YFP knock-in allele that reads out Arg1 expression [19].
Therefore, our system tests Arg1 function in macrophages,
because these are the main cells that express Arg1, regardless of
the broader expression of the cre deleter used.
As a result, thioglycollate-elicited macrophages isolated from
Arg1
2/flox;LysMcre mice showed markedly reduced arginase activity
when examined ex vivo (Figure 1A). Arg1
2/flox;LysMcre macro-
phages also showed a significant reduction in arginase activity
following stimulation with the Th2 cytokines IL-4, IL-13, and IL-
21 [10] (approximately 7-fold decrease from Arg1
flox/flox controls).
In contrast, NO production remained intact (Figure 1B), and was
slightly elevated following IFN-c/LPS stimulation. The Arg1-
deficiency in macrophages did not alter the expression of other
markers of alternative activation since thioglycolate-elicited
macrophages from both Arg1
flox/flox and Arg1
2/flox;LysMcre mice
displayed similar increases in Mrc1 (mannose receptor) and Chi3l3
(Ym1) gene expression following stimulation with IL-4, IL-13, and
IL-21 (Figure 1C). Therefore, Arg1 is not involved in the
development of AAMs but is critically required for Th2
cytokine-inducible arginase activity in macrophages.
Macrophage-specific Arg1 suppresses the development
of fibrosis
To determine whether macrophage specific Arg1 regulates tissue
fibrogenesis, control mice (Arg1
flox/flox) and Arg1
2/flox;LysMcre litter
mates were percutaneously exposed to 35 S. mansoni cercariae and the
progressive development of fibrosis was assessed in the liver at 9
(acute), 12 (early chronic), and 22 wk (late chronic) post-infection by
measuring hydroxyproline, a modified amino acid found in collagen.
Infectious burdens, assessed by adult worm pairs and tissue egg
counts in the liver and gut, were similar in both Arg1
flox/flox and
Arg1
2/flox;LysMcre mice at all time points, demonstrating that
Arg1-deficiency does not affect susceptibility to infection (Table S1).
In addition, several genes that characterize the development of
AAMs, including Chi3l3 (Ym1) and Retnla(Relm-alpha/FIZZ1), were
increased similarly in the livers of both groups (data not shown),
which was consistent with our in vitro studies with Arg1-deficient
macrophages (Figure 1). Although Arg1 was hypothesized to be
c r i t i c a lf o rc o l l a g e nd e p o s i t i o n[ 1 , 2 ] ,t h eArg1
2/flox;LysMcre mice
showed no impairment in hepatic fibrosis at the acute stage of
infection, and surprisingly, displayed marked and highly significant
increases in fibrosis when chronically infected (Figure 2A). Similar
findings were obtained using second harmonic confocal microscopy,
which can also be used to quantify the collagen content of liver
sections (Figure 2E). The livers of the infected Arg1-deficient mice
were also significantly enlarged at 12 and 22 weeks, providing
evidence of extensive remodeling and regeneration of the liver
(Figure 2B and 2D). The marked increase in hepatic fibrosis in the
Arg1
2/flox;LysMcremice was also associated with enhanced shunting of
eggs to the lungs (Figure 2C), providing evidence of increased portal
hypertension and development of porto-systemic shunts [9],
complications commonly associated with chronic liver fibrosis. Thus,
the Arg1
2/flox;LysMcre mice displayed several pathological features
that characterize the severe hepatosplenic form of schistosomiasis.
These data demonstrate that macrophage-specific Arg1 expression is
not required for the development of Th2 cytokine dependent fibrosis
[2,12]. Instead, the conditional deletion of Arg1 in macrophages
caused a significant exacerbation of schistosomiasis.
Arg1 downregulates chronic inflammation
Although chronic inflammation typically contributes to tissue
remodeling and fibrosis, recent studies have suggested that the
mechanisms controlling inflammation and fibrosis are distinct
[20]. In addition to regulating proline production in macrophages
[11], Arg1 is also involved in the generation of polyamines, which
are important regulators of cellular proliferation [6,21]. Therefore,
to determine whether the development of hepatomegaly and
fibrosis in the infected Arg1
2/flox;LysMcre mice was associated with
changes in inflammation, histological analyses were performed on
liver sections to quantify both granuloma size and the proportion
of various leukocytic cell types within individual granulomas. As
predicted, granuloma size in the Arg1
flox/flox control mice peaked
on wk 9 and subsequently decreased on wks 12 and 22 (Figure 3A).
In contrast to the control mice, however, the infected
Arg1
2/flox;LysMcre mice failed to downmodulate their granuloma-
tous inflammatory response. Instead, their liver granulomas were
nearly 3-fold larger than controls at the chronic stage of infection
and remained of comparable size to the lesions found in acutely
Author Summary
While the function of NOS2 in Th1-type immunity has been
investigated extensively, the role of Arg1 in the regulation
of Th2-type responses is unclear. Previously, we showed
that proline production in AAMs is regulated by Arg1
activity. Because proline is essential for collagen synthesis
in myofibroblasts, numerous studies have suggested that
Arg1-expressing AAMs regulate wound healing and
fibrosis. The development of fibrosis in schistosomiasis is
dependent on Th2 cytokines, and mice deficient in IL-4/IL-
13 fail to upregulate Arg1. Nevertheless, although Arg1
expression is associated with Th2-dependent fibrosis, the
contribution of macrophage-specific Arg1 to the patho-
genesis of fibrosis in schistosomiasis was unknown. The
studies conducted here with two different strains of mice
deficient in macrophage-associated Arg1 demonstrate
unequivocally that Arg1-expressing macrophages exhibit
both anti-inflammatory and anti-fibrotic activity during
Th2-driven inflammatory responses. In schistosomiasis,
fibrosis, portal hypertension, and variceal bleeding are
the primary pathological changes that characterize the
severe hepatosplenic form of the disease in humans. It is
widely believed that people who fail to adequately
activate immune suppressive mechanisms when chroni-
cally infected with S. mansoni are the individuals who
ultimately develop severe disease. Our data identify Arg1-
expressing macrophages as critical mediators of immune
downmodulation in chronic schistosomiasis.
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2/flox;LysMcre mice. A similar increase in
granuloma size was also found in the small intestines of
Arg1
2/flox;LysMcre mice (Figure S1). Similar to the liver, inflam-
mation in the gut was limited to the granulomas with no diffuse
parenchymal component. There was also no unusual histologic
pathology in the gut as was reported in S. mansoni infected
Il4ra
2/flox;LysMcre and Il4
2/2 mice [22,23]. Despite developing
larger lesions, the cellular composition of the Arg1
2/flox;LysMcre
granulomas were similar to controls, with macrophages and
eosinophils predominating in both cases (Figure 3B). A key
difference noted in the Arg1
2/flox;LysMcre granulomas, however,
was a consistent increase in the number of macrophages,
particularly in the chronically infected animals (Figure 3B).
Confocal fluorescent microscopy revealed a small ring of F4/80
+
macrophages in close proximity to the eggs in the control
Arg1
flox/flox mice, while a much larger band of macrophages was
found at the periphery of the Arg1
2/flox;LysMcre granulomas
(Figure 3D). Granuloma-associated liver necrosis was also
Figure 1. Arg1
2/flox;LysMcre mice exhibit reduced Arg1 activity in macrophages. (A) Macrophages were isolated from control (filled bars)
and Arg1
2/flox;LysMcre (open bars) mice and analyzed for arginase activity by measuring urea. Macrophages were isolated and assayed with either
medium alone or treated with a combination of IL-4, IL-13, and IL-21 overnight. (B) Macrophages were assayed for NO by Griess reaction in the
presence of medium, IL-4, IL-13, and IL-21, or IFN-c and LPS (Mean6SEM). (C) RNA from thioglycollate elicited macrophages stimulated with IL-4, IL-
13, and IL-21 was isolated, purified, and assessed for the expression of Mrc1 (mannose receptor) and Chi3l3 (Ym1) (Mean6SEM). All assays were
repeated with similar results and performed in triplicate.
doi:10.1371/journal.ppat.1000371.g001
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flox/flox (filled bars) and Arg1
2/flox;LysMcre (open bars) mice were exposed
to 35 S. mansoni cercariae percutaneously. Mice (n=control/Arg1
2/flox;LysMcre ) were sacrificed at weeks 9 (n=14/14), 12 (n=21/10), and 22 (n=12/
10) post-infection and analyzed for the development of fibrosis and portal hypertension. (A) Collagen was assessed by measuring hydroxyproline and
normalizing to infectious worm pairs per mouse (Mean6SEM). (B) Total animal weight was compared with the weight of total excised liver to
determine liver as a percent of body weight (Mean6SEM). (C) S. mansoni eggs within the lungs of control and Arg1
2/flox;LysMcre mice as an measure
of collateral vessel development and portal hypertension; eggs were enumerated by digesting lungs in 4% KOH at 37uC for 12 hours and 1ml of the
suspension was counted in a Sedgwick-Rafter chamber (Mean6SEM). (D) Representative gross pathology of 22-week infected control and
Arg1
2/flox;LysMcre. Upper arrow indicates presence of S. mansoni eggs which were shunted into the lungs of Arg1
2/flox;LysMcre mice. (E) Individual
liver sections from Control Arg1
flox/flox (top) and Arg1
2/flox;LysMcre (bottom) mice were analyzed for collagen via second harmonic emission (red).
Representative granulomas from 9, 12, and 22 weeks post-infection with S. mansoni. All images were taken at 206magnification. Mean fluorescence
intensities for individual control (filled bars) and Arg1
2/flox;LysMcre (open bars) mice at week 9 (n=14/14), 12 (n=21/10), and 22 (n=12/9) weeks post-
infection with S. mansoni. All assays were repeated three times with similar results.
doi:10.1371/journal.ppat.1000371.g002
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2/flox;LysMcre mice (Figure 3C), most
notably at the 12 wk chronic time point, although in experiments
with increased infectious burdens, significant necrosis was
observed in the Arg1
2/flox;LysMcre mice as early as 9 wk post-
infection (WT: 0.1460.14, KO: 2.7160.61, p,0.001).
Inflammation and fibrosis are exacerbated in
Arg1
flox/flox;Tie2cre mice
We also generated a second mouse strain lacking Arg1 in
macrophages using the Tie2cre deleter mouse (B6.Cg-Tg(Tek-
cre)12Flv/J). Although the Tie2cre mouse can delete floxed genes
in all hematopoietic and endothelial lineage cells, because Arg1 is
expressed in myeloid but not lymphoid lineage cells [19,24], the
different strains provided parallel systems for specifically testing
the function of Arg1 in macrophages in vivo. The Arg1 conditional
knockouts were crossed to Tie2cre mice and backcrossed on both
the BALB/c and C57BL/6 genetic backgrounds so they also
provided a tool to examine the influence of Arg1 activity on two
distinct backgrounds. Macrophages isolated from the Tie2cre cross
were previously shown to develop a near complete ablation of
Figure 3. Macrophage-associated Arg1 inhibits granulomatous inflammation. Week 9 (n=14/14), 12 (n=21/10), and 22 (n=12/9) S.
mansoni–infected control and Arg1
2/flox;LysMcre mice were individually assessed for granuloma volume (Mean6SEM) (A), and individual populations
of small/large lymphocytes, macrophages, fibroblasts, and eosinophils were enumerated (B). Individual granulomas from control (filled bars) and
Arg1
2/flox;LysMcre mice (open bars) were scored for granuloma-associated necrosis on a scale of 1–4 at weeks 9 (n=14/14), 12 (n=21/10) and 22
(n=12/9) post-infection with S. mansoni (mean6SEM) (C). Representative granulomas from 12-week S. mansoni–infected control and
Arg1
2/flox;LysMcre mice were stained with Picrosirius Red 206 or DAPI (blue) and F4/80
+ (green) and photographed at 406. Arrows point to
macrophage-rich regions. Sm=S. mansoni egg (D). All assays were repeated three times with similar results.
doi:10.1371/journal.ppat.1000371.g003
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contrast to the Arg1
2/flox;LysMcre mice, which deleted approx-
imately .85–90% of arginase activity in macrophages [8]. We
used BALB/c and C57BL/6 littermate control Arg1
flox/flox and
Arg1
flox/flox;Tie2cre mice infected with 35 S. mansoni cercariae and
inflammation and fibrosis and examined in the liver (Figure 4A) on
wk 9 (BALB/c and C57BL/6) and wk 12 (C57BL/6) post-
infection. As we observed with the Arg1
2/flox;LysMcre mice, the
Arg1
flox/flox;Tie2cre mice developed significantly larger granulomas
at both time points. Similar results were obtained on both genetic
backgrounds. An increase in granulomatous inflammation was
also observed in the intestines of C57BL/6 Arg1
flox/flox;Tie2cre mice
(Figure 4B). When hydroxyproline was measured in liver,
however, the BALB/c Arg1
flox/flox;Tie2cre mice showed a much
more striking and significant increase in fibrosis on wk 9 when
compared with 9 wk infected C57BL/6 Arg1
flox/flox;Tie2cre mice
(Figure 4A, lower panel). Nevertheless, by wk 12, the C57BL/6
Arg1
flox/flox;Tie2cre also displayed a notable increase in fibrosis. As
such, these data suggest that macrophages are the critical cell type
producing Arg1 in S. mansoni infection because the LysMcre and
Tie2cre mice were remarkably concordant.
Arg1 protects mice from the lethal effects of Th2
pathology
To test whether IL-4/IL-13-induced arginase activity in
macrophages was critical to the development of morbidity and
mortality in schistosomiasis, we analyzed the survival of Arg1
flox/flox
and Arg1
2/flox;LysMcre mice following infection with S. mansoni
cercariae. Egg deposition in the liver commences approximately 4
wk post-infection, with peak granuloma-associated inflammation
occurring by wk 8. However, despite vigorous inflammatory
responses, both groups showed little to no mortality through wk 9
of infection. Nevertheless, as the infection progressed to the
chronic stage, a significant difference in survival was observed
between the Arg1
flox/flox and Arg1
2/flox;LysMcre mice, with˜40% of
the Arg1
2/flox;LysMcre mice succumbing to the infection by wk 12
(Figure 5A). No mortality was observed in the Arg1
flox/flox control
group during this period. Additional studies were also performed
with a dose of parasites that induces mortality in WT animals.
Here, the Arg1
2/flox;LysMcre mice also displayed an accelerated
time to death, with only 20% of the Arg1-deficient mice surviving
beyond wk 10. In contrast, only 50% of the Arg1
flox/flox mice died
by wk 12 (Figure 5A). To dissect the possible mechanisms for the
increased mortality, we examined whether iNOS activity was
involved. For these studies, the Arg1
2/flox;LysMcre mice were
treated with aminoguanidine to inhibit iNOS, as Arg1 activity is
thought to potently antagonize NO production [3,25]. Although
the dose of aminoguanidine we used is highly effective at blocking
NOS2 activity in vivo [26,27], the inhibitor had no effect on the
survival of the Arg1
2/flox;LysMcre mice (Figure 4B). We also
examined the serum levels of LPS and determined that endotoxin
was not significantly increased in either group (Figure 5F),
indicating that there was no disruption in gut barrier function as
has been reported in S. mansoni infected Il4
2/2 and Il4ra
2/flox;LysMcre
mice [23,28,29]. Finally, while both groups displayed significant
increases in serum AST, ALT, and alkaline phosphatase following
infection, the amounts in Arg1
2/flox;LysMcre mice were comparable to
control mice at all time points (Figure 5C–5E). Together, these
observations suggest that the cause of death in the Arg1
2/flox;LysMcre
mice is distinct from the mechanism observed in Il4
2/2 and
Il4ra
2/flox;LysMcre mice [23,28], which was attributed to acute Th1
cytokine and endotoxin-mediated toxicity. Instead, we frequently
observed blood in the intestine of the infected Arg1
2/flox;LysMcre mice
at autopsy.
Arg1-expressing AAMs inhibit CD4
+ T cell proliferation
and cytokine production
Although AAMs were previously shown to protect mice from
the highly lethal effects of Th1-type pathology [23], our data
demonstrate that macrophages expressing Arg1 are required for
the suppression of Th2-associated morbidity and mortality in
chronic schistosomiasis. To identify a mechanism that could
explain the increased inflammatory and fibrotic responses in
Arg1
2/flox;LysMcre mice, we first examined whether T regulatory
cell function was altered in the granulomatous tissues as Tregs are
thought to play an important role in the downregulation of egg-
induced pathology during S. mansoni infection [9]. While significant






flox/flox;Tie2cre mice develop exacerbated in-
flammation and fibrosis. (A) BALB/c control (n=5), BALB/c
Arg1
flox/flox;Tie2cre (n=5), C57BL/6 control (n=5), and C57BL/6
Arg1
flox/flox;Tie2cre (n=7) were infected with S. mansoni cercariae and
euthanized on week 9 and assessed individually for granuloma volume
and fibrosis. Additional control (n=6) and C57BL/6 Arg1
flox/flox;Tie2cre
(n=5) were examined on week 12. The data show the means6SEM;
significant differences are noted in the figure. (B) Granuloma volumes
were measured in the intestines of control and C57BL/6
Arg1
flox/flox;Tie2cre on week 12 (Mean6SEM). A second experiment
produced similar results.
doi:10.1371/journal.ppat.1000371.g004
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differences noted in control and Arg1
flox/flox;LysMcre mice (Figure




+ effector T cells in the
Arg1
2/flox;LysMcre mice. Therefore, to determine whether Th1,
Th2, or Th17 cytokine responses were altered, lymphocytes were
isolated from the granulomatous livers and intracellular cytokine
staining was performed for IFN-c, IL-17, IL-4, IL-5, and IL-13.
While no significant differences were noted in the frequency of
cytokine producing cells in the liver (Figure 6A and 6B), we
detected a consistent and significantincrease inthe production ofIL-
4, IL-5, and IL-13 in CD4
+ T cells isolated from Arg1
2/flox;LysMcre
mice (Figure 6C). A small increase in IFN-c was also observed, while
IL-17wassimilarinbothgroups.Wealsodetectedincreasedlevelsof
IL-5 in the serum of Arg1
2/flox;LysMcre mice (data not shown). In
addition, in vivo proliferation studies conducted with bromodeoxy-
uridine (BrdU) incorporation and flow cytometric analysis suggested
that the Arg1
2/flox;LysMcre mice CD4
+ T cells were proliferating
more than WT cells (Figure 6D). Together, these data indicated that
the Arg1
2/flox;LysMcre mice were developing exaggerated effector T
cells responses, thus providing a mechanism for the enhanced Th2-
dependent pathology.
Figure 5. Arg1-expressing AAMs regulate survival after S. mansoni infection. Control Arg1
flox/flox and Arg1
2/flox;LysMcre mice were infected
with S. mansoni for 12 or 22 weeks, and survival was monitored. (A) Survival rates for week 12 (n=21/20) and 22 (n=12/15) control and
Arg1
2/flox;LysMcre mice infected with 35 cercariae or week 22 mice (n=5/5) infected with 100 cercariae. (B) Survival of control (n=8) and
Arg1
2/flox;LysMcre (n=9) mice infected with 35 cercariae in the presence of the NO inhibitor aminoguanidine (2.5% in drinking water). Individual
serum samples were isolated from control and Arg1
2/flox;LysMcre mice infected with S. mansoni for 9, 12, and 22 weeks. Samples were analyzed for
liver enzymes and LPS. (C) AST/GOT. (D) Alkaline Phosphatase. (E) ALT/GPT. (F) Endotoxin. All assays were repeated three times with similar results.
doi:10.1371/journal.ppat.1000371.g005
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inflammatory’’ mediators [30], we investigated whether Arg1 was
required by alternatively-activated macrophages to inhibit antigen
specific T cell proliferation. For these studies, macrophages were
prepared from both WT and Arg1
2/flox;LysMcre mice and treated
with a cocktail of IL-4/IL-13/GM-CSF for 36 hr to induce
alternative activation before the addition of CFSE labeled lymph
node cells isolated from OT-II mice and cognate OVA peptide.
Strikingly, while untreated WT and KO macrophages induced
robust T cell proliferation, WT cells pretreated with IL-4/IL-13/
GM-CSFcompletelyfailedtostimulateTcellproliferation(Figure7).
In marked contrast, AAMs generated from Arg1
2/flox;LysMcre mice
behaved like untreated macrophages, indicating that Th2-induced
Arg1 expression is required for the suppressive activity of AAMs.
Next, we examined if IL-10 and TGF-b1w e r er e q u i r e df o rt h e
suppressiveactivity.Forthese studies macrophagesweretreatedwith
increasing doses of IL-4, IL-13, and GM-CSF for 36 h prior to
introduction of CSFE-labelled OVA-specific T cells. In some
cultures, neutralizing mAbs to TGF-b1 or IL-10 were included
either alone or in combination.
While unstimulated macrophages induced robust T cell
proliferation, as little as 0.2 ng/ml of IL-4/IL-13/GM-CSF was
sufficient to inhibit proliferation by 80–90% (Figure 8A, red vs.
orange). Higher doses inhibited T cell proliferation completely.
Importantly, the introduction of neutralizing mAbs to IL-10 and
TGF-b1 to the cultures had no effect. In parallel we also examined
whether competition between AAMs and T cells for arginine
might be responsible for the suppressive activity. When the
cultures were supplemented with excess L-arginine, proliferation
was restored (Figure 8B) and dependent on the dose of IL-4/IL-
13/GM-CSF added to the cultures: when the macrophages were
pre-treated with a high dose of IL-4/IL-13/GM-CSF (5 ng/ml) to
induce alternative activation, large quantities of excess L-arginine
(1000 mmoles) were required to restore CD4
+ T cell proliferation
(Figure 8B, left panel). In contrast, when lower doses of Th2
cytokines were used (1.0 or 0.2 ng/ml), less L-arginine was
required (Figure 8B, middle panels). The addition of L-arginine
alone had no effect on T cell proliferation when control
macrophages were used, and it even exhibited an inhibitory effect
when used had high doses (Figure 8B, right panel).
Finally, to determine whether T cells isolated from S. mansoni
mice would respond in a similar manner, CD4
+ T cells were
isolated from infected mice and soluble egg antigens (SEA) were
used as the antigenic stimulus. Macrophages isolated from either
control Arg1
flox/flox and Arg1
2/flox;LysMcre mice were used as the
APCs. Macrophages were either left unstimulated or pre-treated
with IL-4, IL-13, and GM-CSF (Figure 9). Unstimulated WT
macrophages stimulated robust T cell proliferation in response to
SEA whether WT (Figure 9A) or KO (Figure 9C) CD4
+ T cells
were employed. In contrast, when WT macrophages were
pretreated with IL-4/13/GM-CSF, SEA-specific T cell prolifer-
ation was reduced (Figure 9A and 9C), thus supporting our earlier
studies with OVA-specific T cells (Figure 8). However, when
Arg1
2/flox;LysMcre macrophages were used as APCs, the pre-
treatment with IL-4/13/GM-CSF was not inhibitory (Figure 9B
and 9D). Thus, these data suggest that AAMs were depleting the
available stores of arginine, which is required for T cells to
proliferate when stimulated with SEA. This mechanism may
explain in part why the Arg1




As with most helminth infections, schistosomiasis is associated
with the development of a CD4
+ Th2 cell response [9]. Pearce and
colleagues showed that survival during acute S. mansoni infection is
highly dependent on IL-4 signaling [22,28]. In the absence of IL-4,
C57BL/6 mice exhibit severe cachexia and rapidly succumb to S.
mansoni infection. They concluded that the morbidity was due to
increased TNF-a and nitric oxide production in the affected




mice suggested that in addition to developing hepatotoxicity, the
integrity of the gut epithelium is compromised, leading to
significant inflammation in the ileum, systemic leakage of intestinal
contents, and development of lethal endotoxemia [31,32]. Plasma
levels of LPS also increased nearly 20-fold and recruitment of
eosinophils was dramatically reduced in the intestines, confirming
that the acute mortality of Il4
2/2 mice was due to the increased






[22,29,31,32], mice that are genetically deficient in AAMs
(Il4ra
2/flox;LysMcre) displayed 100% mortality when acutely
infected with S. mansoni [23]. Here again, death was associated
with increased Th1 cytokine production, hepatic and intestinal
histopathology, increased NOS2 activity, elevated liver enzymes,
and endotoxemia. The absence of AAMs in these mice, however,
had no effect on the development of fibrosis. Based on these
Figure 7. Arg1-expressing AAMs suppress T cell proliferation.
Day-4 thioglycollate-elicited peritoneal macrophages from WT or
Arg1
2/flox;LysMcre mice were treated with 1 ng/ml of cytokine cocktail
(IL4+IL13+GM-CSF) for 36 hours before addition of CFSE labeled LN cells
from OT-II mice and cognate OVA peptide. Proliferation of CD4
+ cells
was examined at 96 hours of co-culture in RPMI+10% FCS. The
experiment was repeated twice with similar results.
doi:10.1371/journal.ppat.1000371.g007
Figure 6. Arg1-expressing AAMs suppress Th2 cytokine production. Liver leukocytes isolated from 9-week S. mansoni–infected mice were
separated, counted, and cultured with PMA, Ionomycin, and Brefeldin A for 3 hours and analyzed for ex-vivo cytokine production capability. (A)
Representative FACS plots of IL-13, IL-4, IL-5, IFN-c, and IL-17-producing CD4
+ T cells. (B) Total number of cytokine-producing CD4
+ cells in the liver
leukocyte preparation (n=7/group). (C) Magnitude of cytokine production by CD4
+ cells displayed as geometric mean of fluorescence intensity.
Statistically significant differences are shown (n=7/group). (D) 9-week S. mansoni–infected mice were treated with BrdU for 3 days by i.p. injection
prior to sacrifice, and then mesenteric lymph nodes cells were isolated and stained for CD4
+ and BrdU incorporation (n=3/group). All experiments
were repeated twice with similar results.
doi:10.1371/journal.ppat.1000371.g006
Macrophage Arginase-1 Suppresses Th2 Immunity
PLoS Pathogens | www.plospathogens.org 9 April 2009 | Volume 5 | Issue 4 | e1000371observations, the authors concluded that IL-4Ra signaling in
AAMs is critical for host survival in acute S. mansoni infection [23].
These findings were important because they suggested that the
protective activity of the Th2 response in schistosomiasis is directly
linked to its role in promoting the differentiation of AAMs.
Because hepatic fibrosis, portal hypertension, and variceal
bleeding are the primary causes of morbidity and mortality in
human schistosomiasis [33], our research has focused on
understanding the mechanisms regulating the development of
chronic Th2-associated pathology [2]. Indeed, when mice are
persistently infected with S. mansoni, the chronic Th2 response itself
becomes highly pathogenic [34]. Previous studies with various
cytokine deficient mice demonstrated that Th2 cytokines are
critical to the development of hepatic fibrosis, portal hypertension,
bleeding from collateral vessels, and ultimately death in schisto-
somiasis [10,31,35–37]. In chronically infected mice, morbidity
and mortality primarily results from fibrosis-associated pathology
instead of the ‘‘Th1 cytokine storm’’ and resulting endotoxic/






2/flox;LysMcre mice [33]. In support of this
conclusion, mice that are deficient in either IL-13 or IL-13Ra1 are
protected from fibrosis and they survive significantly longer than
chronically infected WT mice [31,38,39]. Consequently, depend-
ing on the duration and magnitude of the infection, Th2 cytokines
exhibit both protective (IL-4, acute infections) and pathogenic (IL-
13, chronic infections) activity in the mouse model of schistoso-
miasis [40,41]. Surprisingly, the development of Th2-driven
fibrosis appeared normal in S. mansoni infected AAM-deficient
Il4ra
2/flox;LysMcre mice [23]. Consequently, Herbert and col-
leagues concluded that AAMs are not required for Th2-dependent
granuloma formation or fibrosis in schistosomiasis. Nevertheless,
because 100% of the infected Il4ra
2/flox;LysMcre mice died at the
acute stage of infection, it was impossible to evaluate the role of
AAMs in chronic schistosomiasis using these mice.
In contrast to Il4ra
2/flox;LysMcre mice, AAMs develop normally
in Arg1
2/flox;LysMcre mice; however, their macrophages are
deficient in the key gene that differentiates AAMs from other
macrophage subpopulations [1]. Thus, by specifically targeting
Arg1 in macrophages, our conditional knockout mice provided an
ideal tool to dissect the role of AAMs in chronic schistosomiasis.
Strikingly, in contrast to the findings with Il4ra
2/flox;LysMcre mice,
our data suggest that Arg1-expressing AAMs are not required to
suppress acute Th1/NOS2/LPS-mediated morbidity and mortal-
ity in schistosomiasis. Indeed, we obtained no evidence that the
Arg1
2/flox;LysMcre mice were developing lethal endotoxemia or
hepatotoxicity during acute schistosome infection. Concordant
results were obtained with Arg1
flox/flox;Tie2cre mice, which we
showed have an almost complete deletion of Arg1 in all
macrophage types examined [8]. Instead, our data suggest that
the major function of Arg1 is to downmodulate granulomatous
Figure 8. The suppressive activity of AAMs is IL-10 and TGF-b independent. (A) Day 4 peritoneal macrophages from thioglycollate-injected
WT mice were treated with increasing doses of a cytokine cocktail of IL-4, IL-13, and GM-CSF for 36 hours before addition of CFSE-labeled LN cells
from OT-II mice and cognate OVA peptide. Proliferation of CD4
+ cells was examined at 96 hours of co-culture in RPMI+10% FCS. Some groups were
also treated with anti-TGF-b (10 mg/ml), anti-IL-10 (10 mg/ml), or a combination of both mAbs when T cells were added to the macrophage APCs. (B)
In a second series of experiments, the macrophage/T cell cultures were supplemented with L-arginine hydrochloride at the indicated concentrations,
again at the time when T cells were added. All experiments were repeated three times with similar results.
doi:10.1371/journal.ppat.1000371.g008
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of Th2-dependent fibrosis in chronically infected mice. As such,
our studies identified a novel role for AAMs in the pathogenesis of
schistosomiasis. These results also illustrated the importance of
investigating the specific contributions of the unique genes that
characterize AAMs [19,42], in addition to analyzing the function
of AAMs as a whole [13,15,23,43].
Th2-activated macrophages have had long history of being
described as ‘suppressor’ cells [30]. Nevertheless, most of these
studies have concentrated on the role of myeloid-derived
suppressor cells (MDSCs) in cross-regulating type-1 immunity
and inhibiting the function of classically activated macrophages
[24,44–50]. Indeed, the role of Arg1-expressing macrophages in
the regulation of Th2 responses is much less clear. Fortunately, the
Arg1
2/flox;LysMcre mice provided an ideal model system to formally
test the activity of macrophage-derived Arg1 in an important Th2
disease model. The results from our studies demonstrate that IL-
4/IL-13-activated macrophages potently inhibit T cell prolifera-
tion. T cell proliferation was restored when Arg1 activity was
deleted in AAMs or when WT AAMs were provided exogenous
arginine, illustrating a critical role for arginine depletion in the
suppressive activity of Arg1
+ AAMs [24]. No significant contribu-
tion for IL-10 or TGF-b1 was observed in these studies, suggesting
that arginine depletion by Arg1-expressing macrophages was the
primary suppressive mechanism. In agreement with these
observations, the Th2 cytokine response was enhanced in the
infected Arg1
2/flox;LysMcre mice. Moreover, BrdU incorporation
studies confirmed a suppressive role for Arg1 in vivo. Thus, these
studies demonstrated unequivocally that Arg1-expressing AAMs
function as potent inhibitors of chronic Th2 responses [24,48].
Several previous studies suggested that AAMs promote the
development of CD4
+ Th2 cell responses in vivo [51–53].
Nevertheless, not only were Arg1 expressing macrophages not
required for the development of Th2 responses or fibrosis, our
data showed that they inhibit these responses. Therefore, it will be
important to determine whether this macrophage-associated Arg1-
dependent mechanism is operating in other Th2-associated
diseases [21]. It will also be important to determine whether the
depletion of L-arginine by alternatively-activated macrophages in
specific microenvironments like granulomas or tumors contributes
to the local suppression of T cell responses and/or myofibroblast
activity in vivo.
While macrophage-specific Arg1 was originally hypothesized to
be an inducer of Th2-driven pathology [1,2,43,54], the studies
conducted here with Arg1
2/flox;LysMcre and Arg1
flox/flox;Tie2cre
mice revealed an unanticipated function for the Th2-inducible
Arg1 isoform. Instead of promoting Th2 disease, our data suggest
that macrophage-specific Arg1 contributes to the resolution of
Figure 9. Arg1 is required to suppress schistosome-specific T cell proliferation. 2610
5 thioglycollate-elicited macrophages from (WT)
control Arg1
flox/flox (A,C) and (KO) Arg1
2/flox;LysMcre mice (B,D) were pre-treated with a cocktail of IL-4/IL-13/GM-CSF at a concentration of 1 ng/ml of
each cytokine or PBS. CD4
+ cells were isolated from the livers of 9-week S. mansoni–infected WT (A,B) or Arg1
2/flox;LysMcre mice (C,D), labeled with
CFSE, and then added to the macrophage cultures at a concentration of 1610
5 cells per well in RPMI+10% FCS. Wells were either left unstimulated
(Med) or stimulated with 20 mg/ml of SEA. After 84 hours, proliferation was analyzed by flow cytometry and represented as the percentage of CD4
cells that had divided in each of the conditions. The experiment was conducted twice with similar results.
doi:10.1371/journal.ppat.1000371.g009
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+ T cell effector function. It is
also possible that the increased collagen deposition in the knockout
mice results from changes in competition for L-arginine by the
cytosolic and mitochondrial arginase isoforms. The net arginine-
to-proline conversion could be higher in Arg1 null macrophages
than in WT macrophages because of differential subcellular
compartmentation of ornithine-metabolizing enzymes, which
function downstream of the arginases. For example, the cytosolic
Arg1 in WT macrophages may compete for substrate with the
mitochondrial Arg2, thus diverting ornithine preferentially to a
different metabolic fate than ornithine produced by Arg2 within
mitochondria. Consequently, the metabolic fate of ornithine in
Arg1 null macrophages could be shifted dramatically from the fate
observed in WT macrophages. Finally, it is also possible that Arg1-
expressing macrophages are simply competing with fibroblasts for
L-arginine and in the absence of macrophage-specific Arg1, more
substrate is available to activated myofibroblasts, resulting in
increased collagen production. Indeed, all three of these
mechanisms could be contributing the exacerbated fibrosis
observed in the infected macrophage-specific Arg1 null mice.
Recently, we showed that Arg1-expressing macrophages also
regulate type-1 responses [8]. However, in contrast to diseases
dominated by Th2-type cytokines in which Arg1 expression is
greatly increased by IL-4 and 13 signaling through the transcription
factor STAT6 [11,55], during Th1 responses a novel TLR-
dependent but STAT6-independent pathway of Arg1 expression
was identified [8]. In this case, the specific elimination of Arg1
increased production of the anti-microbial mediator NO, which
favored host survival during T. gondii infection and decreased lung
bacterial loads during tuberculosis. Therefore, although macro-
phage Arg1 expression is more commonly associated with AAMs
found in helminth infections and allergic reactions, we discovered
that CAMs also produce Arg1. The combined results from both
studies suggest that macrophage-derived Arg1 exhibits important
but distinct regulatory activities during Th1 and Th2-type immune
responses. During Th1 responses, CAM-derived Arg1 antagonizes
NOS2 activity, which promotes infection by intracellular patho-
gens, while in Th2 responses Arg1-expressing AAMs contribute to
the resolution of chronic Th2-driven inflammation and fibrosis by
functioning as suppressor cells.
Methods
Ethics statement
All animal work was conducted according to relevant national
and international guidelines.
Mice, parasite infections
The generation of control Arg1
flox/flox,C 5 7 B L / 6Arg1
2/flox;-
LysMcre , and BALB/c and C57BL/6 Arg1
flox/flox
;Tie2cre mice have
been described [8]. All mice were bred and housed under specific
pathogen-free conditions at the National Institutes of Health in an
American Association for the Accreditation of Laboratory Animal
Care approved facility. The NIAID animal care and use committee
approved all experimental procedures. For infections, mice were
percutaneously exposed via the tail with 30–35 cercariae of a Puerto
Rican Strain of S. mansoni (NMRI) that were obtained from infected
Biomphalaria glabrata snails (Biomedical Research Institute, Rockville,
MD). All animals underwent perfusion at the time of sacrifice so that
worm and tissue egg burdens could be determined.
Histopathology and fibrosis
Pulmonary and hepatic granuloma measurements were deter-
mined from histological sections stained with Wright’s Giemsa or
Picrosirius Red (Histopath of America, Clinton, MD). Thirty
granulomas per mouse were included in all analyses. An
experienced pathologist evaluated the percentages of small and
large lymphocytes, macrophages, fibroblasts, and eosinophils in
the same sections. The number of schistosome eggs in the liver and
the gut and the collagen content of the liver, as measured by
hydroxyproline levels, were determined as previously described
[11]. Hepatic collagen was measured after hydrolysis of a 200-mg
portion of liver in 5 ml of 6N HCl at 110uC for 18 h. The increase
in hepatic hydroxyproline was positively related to egg numbers in
all experiments and hepatic collagen is reported as the increase
above normal liver collagen in micromoles per 10,000 eggs;
(infected liver collagen – normal liver collagen)/liver eggs 610
24
or micromoles per worm pair. At late chronic time points, fibrosis
is reported as total liver collagen per liver. The same individual
scored all histological features and had no knowledge of the
experimental design.
Aminoguanidine treatments
Mice were given a 2.5% solution of AG hemisulfate (Sigma, St.
Louis, Mo.) in sterilized drinking water on week 6–12 following S.
mansoni exposure [26,27]. The dose employed was shown
previously to completely suppress nitric oxide production in
infected mice [56].
Peritoneal macrophages
Peritoneal macrophages were elicited by injecting 3ml of
autoclaved thioglycollate broth i.p/mouse. Macrophages were
harvested 96 hours post i.p injection.
Nitrite analysis and arginase assays
Arginase assays were previously described [10]. Briefly,
neutrophils were plated at 5610
5 per well directly ex vivo in 96
well tissue culture plates, macrophages were plated at a similar
density and stimulated with combinations of IL-4, IL-13, and IL-
21 (20ng/mL). IL-21 was added 6 hours prior to IL-4 or IL-13
stimulation. Following stimulation, cells were washed with PBS
and lysed with 0.1% Triton X-100 containing protease inhibitor
(Roche, Nutley, NJ). Lysates were transferred into a 96 well PCR
plate and incubated with 10mM MnCl2 and 50mM Tris HCl
(pH 7.5) for 10 min at 55uC. 25ul of lysate was removed and
added to 25 ml 1M arginine (pH 9.7) in a new PCR plate and
incubated for 1–2 hours at 37uC. 5 ml of each sample was added
in duplicate to a 96 well ELISA plate along with 5 ml of each
standard, diluted in same assay conditions, starting at 100 mg/dL.
Urea determination reagent from BioAssay Systems Quanti-
chrome Urea Assay Kit (Bioassay Systems, Hayward, CA) was
used according to the manufacturer’s protocol. The concentration
of nitrite in supernatants of thioglycollate elicited macrophages
was determined spectrophotometrically using Griess reagent.
Macrophages were plated at 5610
5 per well in 96 well tissue
culture plates and stimulated with combinations of IL-4 (20ng/
mL), IL-13 (20ng/mL), IL-21 (20ng/mL), IFN-c (100units/mL),
and LPS (100ng/mL). Supernatants were collected after 24 hours,
mixed 1/1 with Griess reagent, and absorbance measured at
543 nm using a SpectraMax 190 (Molecular Devices, Sunnyvale,
CA). The nitrite concentration was determined using sodium
nitrite 22 as a standard.
RNA isolation and purification and real time polymerase
chain reaction
Thioglycollate elicited macrophages were lysed with Buffer
RLT (Qiagen Sciences, Valencia, CA), containing 2-mercapto-
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Valencia, CA). Total RNA was extracted using the RNeasy Mini
Kit from Qiagen (Qiagen Sciences, Valencia, CA). Individual
sample RNA (0.1 mg) was reverse-transcribed using Superscript II
(Invitrogen, Carlsbad, CA) and a mixture of oligo (dT) and
random primers. Real- time polymerase chain reaction (RT-PCR)
was performed on an ABI Prism 7900 sequence detection system
(Applied Biosystems, Foster City, CA). Relative quantities of
mRNA for several genes was determined using SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA) and by the
comparative threshold cycle method as described by Applied
Biosystems for the ABI Prism 7700/7900 sequence detection
systems. In this method, mRNAs for each sample were normalized
to hypoxanthine guanine phosphoribosyl transferase (HPRT)
mRNA amounts and then expressed as a relative increase or
decrease compared with uninfected controls. Sequences for
HPRT, Mrc1 (mannose receptor), and Chi3l3 (Ym1) were
published previously [39].
Flow cytometry and ICC
Roughly 200 mg of granulomatous liver tissue was disrupted
into a single cell suspension by grinding through a 70 mm nylon
mesh. The WBCs from liver cells were separated on a 34% Percoll
gradient (3506g for 20 min) (Sigma-Aldrich, St. Louis, MO).
MLN and liver WBC’s were treated with 2 ml of ACK lysis buffer
(Quality Biological, Gaithersburg, MD) for 2 min. ICC: Liver
leukocytes were stimulated with PMA (10ng/ml), Ionomycin (1ug/
ml) and BFA (10ug/ml) (Sigma) for 3 hrs. Cells were surface
stained for CD4 APC (BD Biosciences, San Jose, CA), fixed in 2%
formaldehyde for 20 min at RT, permeabolized with 0.1%
saponin buffer (Sigma-Aldrich, St. Louis, MO) and stained for
IL-13 FITC (Centocor, Wayne, PA) and acquired with FACS
Calibur (BD Biosciences, San Jose, CA). Data were analyzed using
Flowjo V7.2.
Microscopy
Portions of livers from control and Arg1
2/flox;LysMcre S.
mansoni infected mice were removed and frozen in liquid
nitrogen. Cryostat-cut tissue sections (8 mm) were fixed in
acetone and stained with the following reagents: F4/80 Alexa
647 (Invitrogen, Carlsbad, CA), and VECTASHIELD HardSet
Mounting Medium with DAPI (Vector Laboratories, Burlin-
game, CA). Slides from weeks 9, 12, and 22 post infection were
analyzed for collagen content via second harmonic emission.
Second harmonic emission was generated using a Spectra
Physics MaiTai HP laser tuned to 810nm (Spectra Physics
Corp., CA, USA). Image acquisition was performed on a Leica
SP2 confocal microscope (Leica Microsystems, Exton, PA USA)
using a 206 oil immersion objective NA 0.70, and a dry
condenser, NA. 0.9. The forward propagating signal was
detected using the transmitted light detector. To isolate the
SHG signal et405/20 and SP700nd8 filters were inserted in the
light path between the condenser and detector. (Chroma
Technologies Corporation, Rockingham, VT). The SHG
intensity was detected without polarization selection. Mean
fluorescence intensity was recorded for each individual slide and
averaged for each group as a measure for the presence of
collagen surrounding an individual granuloma.
Endotoxin Measurement
Serum endotoxin was determined using an Endochrome
TM
limulus amebocyte lysate kit (Charles River Laboratories,
Wilmington, MA) per the manufacturer’s specifications.
BrdU proliferation assays and flow cytometry
On approximately wk 8.5 post-infection, groups of WT and
Arg1
2/flox;LysMcre mice were injected with 100 ml BrdU (BD
Pharmingen) at 10mg/ml in sterile PBS for 3 consecutive days
prior to sacrifice. Mesenteric lymph node cells were isolated and
the BrdU flow kit staining protocol provided by Pharmingen was
followed to assess BrdU incorporation and cellular proliferation.
Ex vivo intracellular cytokine staining
Leukocytes isolated from granuloma or mesenteric lymph nodes
were stimulated with PMA (10 ng/ml), Ionomycin (1 mg/ml) and
BFA (10 mg/ml) for 3 hrs. Cells were surface stained with PE-Cy5
conjugated aCD4, fixed in 2% formaldehyde for 20 min. at room
temperature, permeabolized with 0.1% saponin buffer for 30 min.
and further stained with FITC conjugated a-IFN-c, Phycoerythrin
conjugated a-IL-13 (Centocor), Alexa-647 conjugated a-IL-4 and
Allophycocanin conjugated a-IL-5, or conjugated a-IL-17 before
acquiring with FACS Calibur. Antibodies were from BD
Pharmingen except mentioned otherwise. Data were analyzed in
Flowjo V8.
Statistics
Hepatic fibrosis (adjusted for egg number) decreases with
increasing intensity of infection (worm pairs). Therefore, these
variables were compared by analysis of covariance, using the
logarithm of total liver eggs as the covariate and the logarithm of
hydroxyproline content per egg. All other data was analyzed with
Prism (Version 5; GraphPad). Data were considered statistically
significant for P values less than 0.05, obtained with a two-tailed t-
test.
Supporting Information
Figure S1 Larger granulomas form in the liver and gut of
Arg1-/flox;lysMcre mice. Control and Arg1-/flox;lysMcre mice were
infected with 35 S. mansoni cercariae and sacrificed on week 9
post-infection. Individual mice were assessed (n=7, both
groups) for granuloma volume microscopically and reported as
average granuloma volume+SEM. The granulomas in the gut
and liver were significantly larger in Arg1flox/flox;lysMcre mice,
p,0.001.
Found at: doi:10.1371/journal.ppat.1000371.s001 (0.20 MB PDF)
Figure S2 Staining of various activation markers in liver
leukocytes. Liver leukocytes isolated from 9-week S. mansoni-
infected WT and Arg1-/flox;lysMcre mice were separated, counted,
and stained for the various markers shown in the figure. Significant
differences are noted in the figure.
Found at: doi:10.1371/journal.ppat.1000371.s002 (0.57 MB PDF)
TableS1 SchistosomamansoniinfectionincontrolandArg1-/flox;lysMcre
mice. Control and Arg1-/flox;lysMcre mice were infected with 35 S.
mansoni cercariae and sacrificed on weeks 9, 12, and 22 post-
infection. Worm numbers and tissue egg burdens enumerated as
describedinMethods,arepresentedasmean6s.e.m.Aminimumof
10 mice were used in each group. All experiments were repeated at
least two times.
Found at: doi:10.1371/journal.ppat.1000371.s003 (0.02 MB PDF)
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